date,title,source
Oct-23-18,"Aptose to Release Third Quarter Ended September 30, 2018 Financial Results on November 6, 2018",GlobeNewswire
Nov-01-18,Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting,GlobeNewswire
Nov-06-18,Aptose Biosciences: 3Q Earnings Snapshot,Associated Press
Nov-06-18,"Aptose Reports Results for the Third Quarter Ended September 30, 2018",GlobeNewswire
Nov-14-18,"New Research: Key Drivers of Growth for WellCare Health Plans, Streamline Health Solutions, Aptose Biosciences, Houston Wire & Cable, RTI Surgical, and Atlantica Yield  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Nov-20-18,"Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting",GlobeNewswire
Nov-26-18,Aptose Biosciences Doses First Patient in Re-Initiation of Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies,GlobeNewswire
Dec-03-18,OHSU and Aptose Present New CG-806 Preclinical Data at ASH 60th Annual Meeting,GlobeNewswire
Dec-03-18,Aptose Presents New Preclinical Data on CG-806 PAN-FLT3/PAN-BTK Inhibitor at ASH 60th Annual Meeting,GlobeNewswire
Dec-12-18,Aptose Presents Highlights From CG-806 KOL Event,GlobeNewswire
Dec-24-18,Aptose Biosciences Sees Hammer Chart Pattern: Time to Buy?,Zacks
Jan-02-19,"Factors of Influence in 2019, Key Indicators and Opportunity within The TJX Companies, Nasdaq, Werner Enterprises, Global Ship Lease, Domo, and Aptose Biosciences  New Research Emphasizes Economic Growth",GlobeNewswire
Jan-02-19,Aptose Biosciences to Present at Biotech Showcase 2019 Conference,GlobeNewswire
Feb-19-19,Aptose to Present at the 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Feb-20-19,Will Hospice Strength Show on Amedisys' (AMED) Q4 Earnings?,Zacks
Feb-21-19,Will Difficult Comparison Hurt Bio-Rad's (BIO) Q4 Earnings?,Zacks
Feb-25-19,Aptose Biosciences Submits IND Application for CG-806,GlobeNewswire
Feb-26-19,"Aptose To Release Fourth Quarter and Year End December 31, 2018 Financial Results and Hold Conference Call on March 12, 2019",GlobeNewswire
Feb-28-19,Aptose to Present New CG-806 and APTO-253 Data at the 2019 AACR Annual Meeting,GlobeNewswire
Mar-04-19,Aptose Biosciences and CrystalGenomics Announce Issuance of Australian Patent for CG-806,GlobeNewswire
Mar-07-19,Aptose to Participate in Upcoming Investor Conferences in March 2019,GlobeNewswire
Mar-12-19,Aptose Biosciences: 4Q Earnings Snapshot,Associated Press
Mar-12-19,"Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2018",GlobeNewswire
Mar-25-19,Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806,GlobeNewswire
Apr-02-19,Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference,GlobeNewswire
Apr-23-19,"Aptose To Release First Quarter Ended March 31, 2019 Financial Results and Hold Conference Call on May 7, 2019",GlobeNewswire
Apr-24-19,Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2019,GlobeNewswire
May-07-19,Aptose Biosciences: 1Q Earnings Snapshot,Associated Press
May-07-19,"Aptose Reports Results for the First Quarter Ended March 31, 2019",GlobeNewswire
May-10-19,"Aptose Announces Commencement of Previously Announced $20.0 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC",GlobeNewswire
May-13-19,Aptose to Present at May Investor Conferences,GlobeNewswire
May-16-19,Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association,GlobeNewswire
May-24-19,Aptose Biosciences Establishes New At-The-Market Facility,GlobeNewswire
May-29-19,Aptose Announces Proposed Public Offering of Common Shares,GlobeNewswire
May-30-19,Aptose Announces Pricing of Public Offering of Common Shares,GlobeNewswire
May-31-19,Aptose to Present at the Jefferies 2019 Healthcare Conference,GlobeNewswire
